...
首页> 外文期刊>BJU international >Prospective evaluation of safety and efficacy of the supracostal approach for percutaneous nephrolithotomy.
【24h】

Prospective evaluation of safety and efficacy of the supracostal approach for percutaneous nephrolithotomy.

机译:前肋穿刺肾镜取石术的安全性和有效性的前瞻性评估。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To prospectively evaluate the safety and efficacy of the supracostal approach for percu-taneous nephrolithotomy (PCNL), as it is usually avoided because of concerns about potential chest complications. PATIENTS AND METHODS: Between August 1998 and August 2001, 465 patients underwent PCNL. Supracostal access was obtained in 62 patients (63 renal units), comprising 13% of the procedures. The indications for a supracostal approach were staghorn, upper ureteric, superior calyceal stones and high-lying kidneys. The data were analysed for stone clearance, need for additional punctures and the complications associated with supracostal puncture. RESULTS: The supracostal was the only access in 63% of the PCNL procedures. Additional punctures were required mainly for staghorn stones (15 of 23). Overall, 90% of the patients were rendered stone-free or had clinically insignificant residuals with PCNL alone. In patients with staghorn stones, they were completely cleared in 84% of renal units. Significant chest complications developed in three (5%) patients, which required insertion of a chest tube. One (2%) patient developed haemothorax secondary to injury of the intercostal artery. All the patients recovered uneventfully. CONCLUSIONS: These results indicate that supracostal access provides high clearance rates with acceptable complications; it should not be avoided for fear of chest complications. A chest X-ray after surgery should be routine, to detect any complication.
机译:目的:前瞻性评估经肋膜上肾镜取石术(PCNL)的安全性和有效性,因为考虑到可能的胸部并发症,通常应避免这种方法。患者与方法:在1998年8月至2001年8月之间,有465例患者接受了PCNL。经肋上入路的有62例患者(63个肾单位),占手术的13%。肋上上入路的适应证是鹿角,输尿管上段,肾盂上段结石和高位肾脏。分析了结石清除率,是否需要额外穿刺以及肋上穿刺相关并发症的数据。结果:上肋膜是63%的PCNL手术中唯一的通路。主要需要对鹿角结石进行额外的穿刺(23个中的15个)。总体而言,仅PCNL可使90%的患者免于结石或临床上无残留。鹿角结石患者的肾单位中有84%完全清除了结石。三(5%)例患者出现了严重的胸腔并发症,需要插入胸管。一名(2%)患者继发肋间动脉损伤后出现了血胸。所有患者康复良好。结论:这些结果表明,肋上入路可提供较高的清除率,并具有可接受的并发症。避免因为担心胸部并发症而避免使用它。术后应常规进行胸部X光检查,以发现任何并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号